TBRG vs HCKT vs MTEX vs HIMS vs INVA

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -10. 7% for Mannatech, Incorporated (MTEX). Mannatech, Incorporated (MTEX) offers the better valuation at 3. 5x trailing P/E, making it the more compelling value choice. Analysts rate The Hackett Group, Inc. (HCKT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Mannatech, Incorporated (MTEX) is the cheapest at 3.

5x versus TruBridge, Inc. at 88. 9x. On forward P/E, The Hackett Group, Inc. is actually cheaper at 6. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Hackett Group, Inc. wins at 0. 31x versus Innoviva, Inc. 's 1. 15x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -61. 0% for Mannatech, Incorporated (MTEX). Over 10 years, the gap is even starker: HIMS returned +161. 9% versus TBRG's -36. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Innoviva, Inc.

(INVA) is the lower-risk stock at 0. 13β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 1805% more volatile than INVA relative to the S&P 500. On balance sheet safety, Innoviva, Inc. (INVA) carries a lower debt/equity ratio of 23% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -10. 7% for Mannatech, Incorporated (MTEX). On earnings-per-share growth, the picture is similar: Innoviva, Inc. grew EPS 816. 7% year-over-year, compared to -55. 2% for The Hackett Group, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Innoviva, Inc.

(INVA) is the more profitable company, earning 63. 8% net margin versus 1. 3% for TruBridge, Inc. — meaning it keeps 63. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INVA leads at 38. 5% versus 1. 2% for MTEX. At the gross margin level — before operating expenses — MTEX leads at 77. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, The Hackett Group, Inc. (HCKT) is the more undervalued stock at a PEG of 0. 31x versus Innoviva, Inc. 's 1. 15x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Hackett Group, Inc. (HCKT) trades at 6. 9x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 44. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HCKT: 79. 7% to $20. 50.

In this comparison, HCKT (4.

1% yield) pays a dividend. TBRG, MTEX, HIMS, INVA do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Innoviva, Inc.

(INVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13)). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (INVA: +94. 9%, HIMS: +161. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (TBRG (Healthcare) and HCKT (Technology) and MTEX (Consumer Defensive) and HIMS (Healthcare) and INVA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: TBRG is a small-cap quality compounder stock; HCKT is a small-cap income-oriented stock; MTEX is a small-cap deep-value stock; HIMS is a small-cap high-growth stock; INVA is a small-cap high-growth stock. HCKT pays a dividend while TBRG, MTEX, HIMS, INVA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.